Pirfenidone ameliorates liver steatosis by targeting the STAT3-SCD1 axis
ConclusionIn summary, our data reveal that PFD may play an important role in mitigating hepatic steatosis in a STAT3-SCD1-dependent manner.
Source: Inflammation Research - Category: Research Source Type: research
More News: Diets | Eating Disorders & Weight Management | High Fat | Liver | Liver Disease | Nutrition | Obesity | Research | Study | Urology & Nephrology